Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Mar;35(3):e21.
doi: 10.2337/dc11-2306.

Metformin-induced hepatotoxicity

Francisco Miralles-Linares, Susana Puerta-Fernandez, M Rosa Bernal-Lopez, Francisco J Tinahones, Raul J Andrade, Ricardo Gomez-Huelgas
Case Reports

Metformin-induced hepatotoxicity

Francisco Miralles-Linares et al. Diabetes Care. 2012 Mar.
No abstract available

PubMed Disclaimer

Similar articles

  • [Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
    Neye H. Neye H. Pharm Unserer Zeit. 2002;31(3):264-70. doi: 10.1002/1615-1003(200205)31:3<264::AID-PAUZ264>3.0.CO;2-D. Pharm Unserer Zeit. 2002. PMID: 12071123 Review. German. No abstract available.
  • Lactic acidosis associated (or induced by) metformin.
    Ortiz-Lasa M, Gonzalez-Castro A, Peñasco Martín Y. Ortiz-Lasa M, et al. Med Clin (Barc). 2017 Nov 9;149(9):415-416. doi: 10.1016/j.medcli.2017.07.009. Epub 2017 Sep 1. Med Clin (Barc). 2017. PMID: 28865920 English, Spanish. No abstract available.
  • Metformin in type 2 diabetes.
    Fox GN. Fox GN. J Fam Pract. 2004 Nov;53(11):900. J Fam Pract. 2004. PMID: 15527727 No abstract available.
  • Erythema multiforme from metformin.
    Burger DE, Goyal S. Burger DE, et al. Ann Pharmacother. 2004 Sep;38(9):1537. doi: 10.1345/aph.1E074. Epub 2004 Jun 29. Ann Pharmacother. 2004. PMID: 15226487 No abstract available.
  • Metformin in 2019.
    Flory J, Lipska K. Flory J, et al. JAMA. 2019 May 21;321(19):1926-1927. doi: 10.1001/jama.2019.3805. JAMA. 2019. PMID: 31009043 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother 2010;44:1655–1659 - PubMed
    1. Danan G, Benichou C. Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323–1330 - PubMed
    1. Romero-Gómez M, Diago M, Andrade RJ, et al. ; Spanish Treatment of Resistance to Insulin in Hepatitis C Genotype 1 Group. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology 2009;50:1702–1708 - PubMed
    1. Brackett CC. Clarifying metformin's role and risks in liver dysfunction. J Am Pharm Assoc (2003) 2010;50:407–410 - PubMed
    1. Rhee MK, Herrick K, Ziemer DC, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2010;33:49–54 - PMC - PubMed